Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wenger

Showing results (81-90 of 528) with videos related to

Pageof 53
Sort By:
European Journal of Pharmacology|March 12, 1982
Ketamine inhibition of ligand binding to cholinergic receptors and ion channelsR S Aronstam, L Narayanan, D A Wenger
American Journal of Human Genetics|June 1, 1994
Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosisS Chakraborty, M A Rafi, D A Wenger
Clinical Genetics|February 1, 1987
Pseudodeficiency of arylsulfatase A: a counseling dilemmaS Baldinger, M E Pierpont, D A Wenger
Human Mutation|January 1, 1997
Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implicationsD A Wenger, M A Rafi, P Luzi
International Journal of Neonatal Screening|August 27, 2021
Advances in the Diagnosis and Treatment of Krabbe DiseaseDavid A Wenger, Paola Luzi, Mohammad A Rafi
Life Sciences|February 19, 1979
Sphingomyelinase activities in neuronal cell culturesD A Wenger, C Wharton, N W Seeds
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 31, 1991
Leukocyte sonicates as a source for both enzyme assay and DNA amplification for mutational analysis of certain lysosomal disordersE Louie, M A Rafi, D A Wenger
Journal of Neuroscience Research|September 18, 2016
Krabbe disease: One Hundred years from the bedside to the bench to the bedsideDavid A Wenger, Mohammad A Rafi, Paola Luzi
Archives of Neurology|October 12, 2011
Patient with unilateral white matter involvement does not have Krabbe diseaseMarjo S Van der Knaap, David A Wenger
Bioimpacts : BI|May 5, 2020
Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe diseaseMohammad A Rafi, Paola Luzi, David A Wenger
Pageof 53

Showing results (81-90 of 528) with videos related to

Sort By:
Pageof 53
European Journal of Pharmacology|March 12, 1982
Ketamine inhibition of ligand binding to cholinergic receptors and ion channelsR S Aronstam, L Narayanan, D A Wenger
American Journal of Human Genetics|June 1, 1994
Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosisS Chakraborty, M A Rafi, D A Wenger
Clinical Genetics|February 1, 1987
Pseudodeficiency of arylsulfatase A: a counseling dilemmaS Baldinger, M E Pierpont, D A Wenger
Human Mutation|January 1, 1997
Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implicationsD A Wenger, M A Rafi, P Luzi
International Journal of Neonatal Screening|August 27, 2021
Advances in the Diagnosis and Treatment of Krabbe DiseaseDavid A Wenger, Paola Luzi, Mohammad A Rafi
Life Sciences|February 19, 1979
Sphingomyelinase activities in neuronal cell culturesD A Wenger, C Wharton, N W Seeds
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 31, 1991
Leukocyte sonicates as a source for both enzyme assay and DNA amplification for mutational analysis of certain lysosomal disordersE Louie, M A Rafi, D A Wenger
Journal of Neuroscience Research|September 18, 2016
Krabbe disease: One Hundred years from the bedside to the bench to the bedsideDavid A Wenger, Mohammad A Rafi, Paola Luzi
Archives of Neurology|October 12, 2011
Patient with unilateral white matter involvement does not have Krabbe diseaseMarjo S Van der Knaap, David A Wenger
Bioimpacts : BI|May 5, 2020
Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe diseaseMohammad A Rafi, Paola Luzi, David A Wenger
Pageof 53